| scholarly article | Q13442814 |
| P356 | DOI | 10.1172/JCI118162 |
| P953 | full work available at URL | http://www.jci.org/articles/view/118162/files/pdf |
| https://europepmc.org/articles/PMC185749 | ||
| https://europepmc.org/articles/PMC185749?pdf=render | ||
| P3181 | OpenCitations bibliographic resource ID | 4496333 |
| P932 | PMC publication ID | 185749 |
| P698 | PubMed publication ID | 7657802 |
| P50 | author | Yoshihiro Ogawa | Q96682708 |
| P2093 | author name string | Y. Komatsu | |
| K. Nakao | |||
| H. Itoh | |||
| S. Suga | |||
| K. Nishino | |||
| T. Yoshimasa | |||
| O. Nakagawa | |||
| I. Kishimoto | |||
| P2860 | cites work | Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP) | Q24301059 |
| A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation | Q27860824 | ||
| Regulation of rat brain natriuretic peptide transcription. A potential role for GATA-related transcription factors in myocardial cell gene expression | Q28566829 | ||
| Cis-acting sequences that modulate atrial natriuretic factor gene expression | Q33579604 | ||
| Differential regulation of skeletal alpha-actin transcription in cardiac muscle by two fibroblast growth factors | Q33790096 | ||
| Molecular cloning of the complementary DNA and gene that encode mouse brain natriuretic peptide and generation of transgenic mice that overexpress the brain natriuretic peptide gene | Q34142903 | ||
| Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide | Q34184637 | ||
| Proximal regulatory domains of rat atrial natriuretic factor gene | Q67902424 | ||
| Atrial natriuretic peptide elevation in congestive heart failure in the human | Q69987259 | ||
| Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function | Q70031975 | ||
| Augmented expression of atrial natriuretic polypeptide gene in ventricles of spontaneously hypertensive rats (SHR) and SHR-stroke prone | Q70051802 | ||
| Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes | Q70198102 | ||
| Induction of vascular endothelial growth factor gene expression by interleukin-1 beta in rat aortic smooth muscle cells | Q72391861 | ||
| Isolation and sequence determination of rat cardiac natriuretic peptide | Q93519274 | ||
| The cardiac beta-myosin heavy chain isogene is induced selectively in alpha 1-adrenergic receptor-stimulated hypertrophy of cultured rat heart myocytes | Q34248415 | ||
| The amino acid sequence of an atrial peptide with potent diuretic and natriuretic properties | Q34251025 | ||
| Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells | Q34263871 | ||
| Molecular cloning of human prostacyclin receptor cDNA and its gene expression in the cardiovascular system. | Q34323206 | ||
| Human and canine gene homologs of porcine brain natriuretic peptide | Q34476261 | ||
| Increased secretion of atrial natriuretic polypeptide from the left ventricle in patients with dilated cardiomyopathy | Q34563544 | ||
| Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart | Q34564865 | ||
| Molecular biology and biochemistry of the natriuretic peptide system. I: Natriuretic peptides | Q35234095 | ||
| Molecular biology and biochemistry of the natriuretic peptide system. II: Natriuretic peptide receptors | Q35237049 | ||
| Cloning and sequence analysis of cDNA encoding a precursor for rat brain natriuretic peptide | Q35256970 | ||
| Potent and specific inhibitors of protein kinase C of microbial origin | Q35307811 | ||
| Synthesis of atrial natriuretic polypeptide in human failing hearts. Evidence for altered processing of atrial natriuretic polypeptide precursor and augmented synthesis of beta-human ANP. | Q35590430 | ||
| Atrial natriuretic factor and related peptide hormones | Q36417982 | ||
| A hormone-encoding gene identifies a pathway for cardiac but not skeletal muscle gene transcription | Q36652334 | ||
| Transcriptional activation of the cardiac myosin light chain 2 and atrial natriuretic factor genes by protein kinase C in neonatal rat ventricular myocytes | Q36832418 | ||
| mRNA decay: finding the right targets | Q38200044 | ||
| Molecular cloning of hamster brain and atrial natriuretic peptide cDNAs. Cardiomyopathic hamsters are useful models for brain and atrial natriuretic peptides | Q40340356 | ||
| Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system" | Q40512524 | ||
| Divergent regulation of the human atrial natriuretic peptide gene by c-jun and c-fos | Q40653240 | ||
| Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion | Q40919655 | ||
| Natriuretic peptide receptor mRNAs in the rat and human heart | Q41021226 | ||
| Differential regulation of the expression of fast-type sarcoplasmic-reticulum Ca(2+)-ATPase by thyroid hormone and insulin-like growth factor-I in the L6 muscle cell line | Q41435428 | ||
| Phorbol ester stimulates the synthesis and secretion of brain natriuretic peptide from neonatal rat ventricular cardiocytes: a comparison with the regulation of atrial natriuretic factor | Q42503654 | ||
| Removal of poly(A) and consequent degradation of c-fos mRNA facilitated by 3' AU-rich sequences | Q42514371 | ||
| Human brain natriuretic peptide, a novel cardiac hormone | Q43970320 | ||
| Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes. A paracrine mechanism for myocardial cell hypertrophy | Q44207696 | ||
| Alpha- and beta-adrenergic stimulation induces distinct patterns of immediate early gene expression in neonatal rat myocardial cells. fos/jun expression is associated with sarcomere assembly; Egr-1 induction is primarily an alpha 1-mediated response | Q44237547 | ||
| Vascular natriuretic peptide | Q44272537 | ||
| Tissue-specific determinants of human atrial natriuretic factor gene expression in cardiac tissue | Q44618303 | ||
| Upstream sequences confer atrial-specific expression on the human atrial natriuretic factor gene | Q44646400 | ||
| Mechanical loading stimulates cell hypertrophy and specific gene expression in cultured rat cardiac myocytes. Possible role of protein kinase C activation | Q44647086 | ||
| Co-regulation of the atrial natriuretic factor and cardiac myosin light chain-2 genes during alpha-adrenergic stimulation of neonatal rat ventricular cells. Identification of cis sequences within an embryonic and a constitutive contractile protein g | Q46155378 | ||
| Cis-Active Determinants of Cardiac-Specific Expression in the Human Atrial Natriuretic Peptide Gene | Q46246027 | ||
| Brain natriuretic peptide is induced by alpha 1-adrenergic agonists as a primary response gene in cultured rat cardiac myocytes. | Q46248299 | ||
| Rat brain natriuretic peptide--tissue distribution and molecular form | Q46880111 | ||
| A new natriuretic peptide in porcine brain | Q48100804 | ||
| Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction | Q48259434 | ||
| Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure | Q48340103 | ||
| Nucleotide sequence of the gene encoding human atrial natriuretic factor precursor | Q48384713 | ||
| Augmented secretion of brain natriuretic peptide in acute myocardial infarction | Q48639080 | ||
| Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure | Q48643573 | ||
| Natriuretic peptides as cardiac hormones in normotensive and spontaneously hypertensive rats. The ventricle is a major site of synthesis and secretion of brain natriuretic peptide | Q48682176 | ||
| Expression of brain natriuretic peptide gene in human heart. Production in the ventricle | Q48710286 | ||
| Concentration and molecular forms of brain natriuretic peptide in rat plasma and spinal cord | Q48719299 | ||
| Increased human brain natriuretic peptide in congestive heart failure | Q48897473 | ||
| Neonatal atria and ventricles secrete atrial natriuretic factor via tissue-specific secretory pathways. | Q52259373 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | transcription | Q177900 |
| brain | Q1073 | ||
| regulation of gene expression | Q411391 | ||
| brain natriuretic peptide | Q66360952 | ||
| P304 | page(s) | 1280–1287 | |
| P577 | publication date | 1995-09-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload | |
| P478 | volume | 96 |
| Q42317064 | A Novel Role for Brain Natriuretic Peptide: Inhibition of IL-1β Secretion via Downregulation of NF-kB/Erk 1/2 and NALP3/ASC/Caspase-1 Activation in Human THP-1 Monocyte. |
| Q48387167 | A prospective cohort study of prognostic power of N-terminal probrain natriuretic peptide in patients with non-ST segment elevation acute coronary syndromes |
| Q48646914 | Activation pattern of MAPK signaling in the hearts of trained and untrained rats following a single bout of exercise |
| Q35200873 | Acute decompensated heart failure: a contemporary approach to pharmacotherapeutic management |
| Q36266039 | Acutely decompensated congestive heart failure: new therapies for an old problem |
| Q40426379 | Adult mice expressing a Braf Q241R mutation on an ICR/CD-1 background exhibit a cardio-facio-cutaneous syndrome phenotype |
| Q44075487 | Aldosterone augments endothelin-1-induced cardiac myocyte hypertrophy with the reinforcement of the JNK pathway |
| Q33740807 | Altered gene expression during hypoxia and reoxygenation of the heart |
| Q37676704 | Amotl1 mediates sequestration of the Hippo effector Yap1 downstream of Fat4 to restrict heart growth |
| Q48154510 | Anaemia and renal dysfunction are independently associated with BNP and NT-proBNP levels in patients with heart failure |
| Q33769664 | Analysis of association between brain natriuretic peptide levels and blood pressure variability |
| Q37229313 | Analytical Issues with Natriuretic Peptides - has this been Overly Simplified? |
| Q33899258 | Anemia is independently associated with NT-proBNP levels in asymptomatic predialysis patients with chronic kidney disease |
| Q35215135 | Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney |
| Q48144427 | Angiotensin II-Induced Ventricular Hypertrophy and Extracellular Signal-Regulated Kinase Activation Are Suppressed in Mice Overexpressing Brain Natriuretic Peptide in Circulation |
| Q41891347 | Angiotensin II-induced cardiac hypertrophy and fibrosis are promoted in mice lacking Fgf16. |
| Q54551007 | Angiotensin II-induced cardiomyocyte hypertrophy in vitro is TAK1-dependent and Smad2/3-independent. |
| Q41826860 | Argon Induces Protective Effects in Cardiomyocytes during the Second Window of Preconditioning. |
| Q73901568 | Association between elevated brain natriuretic peptide levels and the development of left ventricular hypertrophy in patients with hypertension |
| Q64066741 | Association between plasma B-type natriuretic peptide and anaemia in heart failure with or without ischaemic heart disease: a retrospective study |
| Q48303041 | Association between serum level of ubiquinol and NT-proBNP, a marker for chronic heart failure, in healthy elderly subjects |
| Q42155507 | Associations between Left Ventricular Cavity Size and Cardiac Function and Overload Determined by Natriuretic Peptide Levels and a Covariance Structure Analysis. |
| Q45182590 | Atrial BNP endocrine function during chronic unloading of the normal canine heart |
| Q33748568 | Attenuation of salt-induced cardiac remodeling and diastolic dysfunction by the GPER agonist G-1 in female mRen2.Lewis rats |
| Q46916529 | Autocrine/paracrine determinants of strain-activated brain natriuretic peptide gene expression in cultured cardiac myocytes |
| Q43990934 | B-type natriuretic peptide after percutaneous transluminal septal myocardial ablation |
| Q35968889 | B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide in pediatric patients with pulmonary arterial hypertension. |
| Q34035094 | B-type natriuretic peptide and high sensitive C-reactive protein predict 2-year all cause mortality in chest pain patients: a prospective observational study from Salta, Argentina |
| Q30885744 | B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study |
| Q35566139 | B-type natriuretic peptide and renal disease |
| Q44038471 | B-type natriuretic peptide as a marker of the effects of enalapril in patients with heart failure |
| Q48717830 | B-type natriuretic peptide in children with atrial or ventricular septal defect: a cardiac catheterization study |
| Q34443720 | B-type natriuretic peptide in the diagnosis and management of congestive heart failure |
| Q33387034 | B-type natriuretic peptide is a long-term predictor of all-cause mortality, whereas high-sensitive C-reactive protein predicts recurrent short-term troponin T positive cardiac events in chest pain patients: a prognostic study |
| Q48089433 | B-type natriuretic peptide levels in congenital heart disease |
| Q48529664 | B-type natriuretic peptide levels in patients with paroxysmal lone atrial fibrillation |
| Q64254486 | BNP and NT-proBNP as Diagnostic Biomarkers for Cardiac Dysfunction in Both Clinical and Forensic Medicine |
| Q35292436 | BNP was associated with ischemic myocardial scintigraphy and death in patients at chest pain unit |
| Q38514901 | Biomarkers for differentiation of causes of respiratory distress in dogs and cats: Part 1--Cardiac diseases and pulmonary hypertension |
| Q37597779 | Biomarkers in outpatient heart failure management; Are they correlated to and do they influence clinical judgment? |
| Q35645118 | Biomarkers of left ventricular hypertrophy and remodeling in blacks |
| Q47755257 | Body fluid status assessment by bio-impedance analysis in patients presenting to the emergency department with dyspnea |
| Q43141703 | Borderline Values of Troponin-T and High Sensitivity C-Reactive Protein Did Not Predict 2-Year Mortality in TnT Positive Chest-Pain Patients, Whereas Brain Natriuretic Peptide Did. |
| Q48791374 | Brain natriuretic peptide appears to act locally as an antifibrotic factor in the heart |
| Q33573360 | Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agent |
| Q48455755 | Brain natriuretic peptide inhibits hypoxic pulmonary hypertension in rats |
| Q43985080 | Brain natriuretic peptide levels in pediatric cancer patients with febrile neutropenia. |
| Q33150831 | Brain natriuretic peptide predicts right heart failure in patients with acute pulmonary embolism |
| Q44631137 | Cardiac expression of urocortin (Ucn) in diseased heart; preliminary results on possible involvement of Ucn in pathophysiology of cardiac diseases |
| Q35677878 | Cardiac fibrosis in mice lacking brain natriuretic peptide |
| Q55409406 | Cardiovascular magnetic resonance assessment of acute cardiovascular effects of voluntary apnoea in elite divers. |
| Q36982605 | Carotid-femoral pulse wave velocity is associated with N-terminal pro-B-type natriuretic peptide level in patients with atrial fibrillation |
| Q92808508 | Change in the NT-proBNP/Mature BNP Molar Ratio Precedes Worsening Renal Function in Patients With Acute Heart Failure: A Novel Predictor Candidate for Cardiorenal Syndrome |
| Q38841451 | Changes in B-type Natriuretic Peptide and Related Hemodynamic Parameters Following a Fluid Challenge in Critically Ill Patients with Severe Sepsis or Septic Shock |
| Q64082877 | Characterisation of N-terminal pro-brain natriuretic peptide in dialysis patients and its reduced prognostic significance in the elderly |
| Q34187119 | Chromogranin B regulates calcium signaling, nuclear factor kappaB activity, and brain natriuretic peptide production in cardiomyocytes |
| Q38011232 | Clinical utility of natriuretic peptides in dialysis patients |
| Q48440308 | Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspnea |
| Q35097344 | Comparison of angiogenic, cytoprotective, and immunosuppressive properties of human amnion- and chorion-derived mesenchymal stem cells |
| Q41039295 | DNA methylation in an engineered heart tissue model of cardiac hypertrophy: common signatures and effects of DNA methylation inhibitors. |
| Q49723566 | Diabetes modifies the role of prostanoids and potassium channels which regulate the hypereactivity of the rabbit renal artery to BNP. |
| Q36732168 | Diagnostic accuracy of N-terminal pro-brain natriuretic peptide in the evaluation of postoperative left ventricular diastolic dysfunction. |
| Q49109750 | Diastolic function and BNP changes during exercise predict oxygen consumption in chronic heart failure patients. |
| Q90109076 | Differential Regulation of ANP and BNP in Acute Decompensated Heart Failure: Deficiency of ANP |
| Q42679244 | Differential expression of B-type natriuretic peptide between left and right ventricles, with particular regard to sudden cardiac death |
| Q52540393 | Disruption of the relationship between renin and atrial natriuretic peptide early in the course of ventricular dysfunction. |
| Q44353130 | Down-regulation of bradykinin B2-receptor mRNA in the heart in pressure-overload cardiac hypertrophy in the rat. |
| Q28506475 | Early cardiac hypertrophy in mice with impaired calmodulin regulation of cardiac muscle Ca release channel |
| Q37020297 | Effect of Breed on Plasma Endothelin-1 Concentration, Plasma Renin Activity, and Serum Cortisol Concentration in Healthy Dogs |
| Q48586362 | Effect of lipopolysaccharide, cytokines, and catecholamines on brain natriuretic peptide release from human myocardium |
| Q48488425 | Effects of angiotensin-converting enzyme inhibitor on plasma B-type natriuretic peptide levels in patients with acute myocardial infarction |
| Q37411132 | Effects of hyperbaric oxygen preconditioning on cardiac stress markers after simulated diving |
| Q45536640 | Efficacy of N-terminal pro-brain natriuretic peptide digit number for screening of cardiac disease in new haemodialysis patients |
| Q48132886 | Endothelin-1 induces expression of fetal genes through the interleukin-6 family of cytokines in cardiac myocytes |
| Q49124024 | Exercise-induced biphasic increase in circulating NT-proBNP levels in patients with chronic heart failure |
| Q48879978 | Expression of B-type natriuretic peptide in atrial natriuretic peptide gene disrupted mice |
| Q73352768 | Expression of kininogen, kallikrein and kinin receptor genes by rat cardiomyocytes |
| Q42683372 | Extremely high conservation in the untranslated region as well as the coding region of CNP mRNAs throughout elasmobranch species. |
| Q48242091 | Factors associated with B-lines after exposure to hypobaric hypoxia |
| Q51948732 | Fgf16 is required for cardiomyocyte proliferation in the mouse embryonic heart. |
| Q35836843 | Gab family proteins are essential for postnatal maintenance of cardiac function via neuregulin-1/ErbB signaling |
| Q34566008 | Gene expression and physiologic responses of the heart to the initiation and withdrawal of caloric restriction. |
| Q34718106 | Genome-wide association analysis and fine mapping of NT-proBNP level provide novel insight into the role of the MTHFR-CLCN6-NPPA-NPPB gene cluster |
| Q35591500 | Genome-wide association analysis of plasma B-type natriuretic peptide in blacks: the Jackson Heart Study |
| Q43512955 | Glucocorticoid regulation of angiotensin-converting enzyme in primary culture of adult cardiac fibroblasts |
| Q52659236 | Glucose-6-phosphate dehydrogenase is critical for suppression of cardiac hypertrophy by H2S. |
| Q24306881 | Hairy-related transcription factors inhibit GATA-dependent cardiac gene expression through a signal-responsive mechanism |
| Q92925812 | Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations |
| Q35771695 | Heart-type fatty acid binding protein is a novel prognostic marker in patients with non-ischaemic dilated cardiomyopathy |
| Q36835416 | Hypertension, hypertrophy, heart failure |
| Q47251020 | Hypoxic pressor response, cardiac size, and natriuretic peptides are modified by long-term intermittent hypoxia |
| Q37307988 | In hypertension, the kidney breaks your heart |
| Q36794956 | In hypertension, the kidney rules |
| Q48083461 | In vitro effects of homologous natriuretic peptides on growth hormone and prolactin release in the tilapia, Oreochromis mossambicus. |
| Q36974293 | Increased expression of HCN channels in the ventricular myocardium contributes to enhanced arrhythmicity in mouse failing hearts |
| Q71244132 | Increased plasma levels of B-type natriuretic peptide in patients with unstable angina |
| Q49142991 | Inducible regulation of human brain natriuretic peptide promoter in transgenic mice |
| Q41730133 | Integrin dependence of brain natriuretic peptide gene promoter activation by mechanical strain |
| Q24296709 | Interaction of BMP10 with Tcap may modulate the course of hypertensive cardiac hypertrophy |
| Q30919400 | Is B-type natriuretic peptide a useful screening test for systolic or diastolic dysfunction in patients with coronary disease? Data from the Heart and Soul Study |
| Q52858483 | Is plasma N-BNP a good indicator of the functional reserve of failing hearts? The FRESH-BNP study. |
| Q43432170 | Isolation and in vitro culture of primary cardiomyocytes from adult zebrafish hearts |
| Q34627221 | MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1(L613V) mutation |
| Q99616593 | Mating-induced increase in Kiss1 mRNA expression in the anteroventral periventricular nucleus prior to an increase in LH and testosterone release in male rats |
| Q33902374 | Mechanical strain activates BNP gene transcription through a p38/NF-kappaB-dependent mechanism |
| Q46066067 | Mechanical strain increases expression of the brain natriuretic peptide gene in rat cardiac myocytes |
| Q84976741 | Midregional Pro–Atrial Natriuretic Peptide for the Diagnosis of Cardiac-Related Dyspnea according to Renal Function in the Emergency Department: A Comparison with B-Type Natriuretic Peptide (BNP) and N-Terminal ProBNP |
| Q37020546 | Molecular cloning and characterization of pigeon (Columba liva) ubiquitin and ubiquitin-conjugating enzyme genes from pituitary gland library |
| Q80761097 | Molecular cloning of natriuretic peptides from the heart of reptiles: loss of ANP in diapsid reptiles and birds |
| Q48853555 | Multicenter evaluation of plasma N-terminal probrain natriuretic peptide (NT-pro BNP) as a biochemical screening test for asymptomatic (occult) cardiomyopathy in cats |
| Q38806580 | Myocardial and haemodynamic responses to two fluid regimens in African children with severe malnutrition and hypovolaemic shock (AFRIM study). |
| Q47641198 | Myocardial stiffness is an important determinant of the plasma brain natriuretic peptide concentration in patients with both diastolic and systolic heart failure |
| Q42428274 | Myocardin-related transcription factor A is a common mediator of mechanical stress- and neurohumoral stimulation-induced cardiac hypertrophic signaling leading to activation of brain natriuretic peptide gene expression |
| Q77513199 | N-terminal pro-brain natriuretic peptide after myocardial infarction: a marker of cardio-renal function |
| Q47876879 | N-terminal prohormone B-type natriuretic peptide and weaning outcome in postoperative patients with pulmonary complications |
| Q46658050 | NT-proBNP response to dobutamine stress echocardiography predicts left ventricular contractile reserve in dilated cardiomyopathy |
| Q26827702 | Natriuretic Peptides and Cardiometabolic Health |
| Q37863198 | Natriuretic peptide system: an overview of studies using genetically engineered animal models |
| Q50683488 | Natriuretic peptide type-B can be a marker of reperfusion in patients with pulmonary thromboembolism subjected to invasive treatment. |
| Q38099221 | Natriuretic peptide-guided therapy: further research required for still-unresolved issues |
| Q34845237 | Natriuretic peptides in relation to the cardiac innervation and conduction system |
| Q37447544 | Natriuretic peptides in the diagnosis and management of chronic heart failure |
| Q48853723 | Natriuretic peptides in the treatment of heart failure |
| Q32063818 | Natriuretic peptides: physiology, therapeutic potential, and risk stratification in ischemic heart disease |
| Q35581437 | Normal values of B type natriuretic peptide in infants, children, and adolescents |
| Q43968441 | Old tool - new application: NT-proBNP in fetal medicine |
| Q48865573 | Olmesartan medoxomil treatment is associated with decreased plasma B-type natriuretic peptide levels in patients on hemodialysis |
| Q75183807 | Patients with acute pulmonary embolism should have an echocardiogram to guide treatment decisions |
| Q58689262 | Pentraxin 3 Released from Neutrophils Increases Plasma Levels in Patients with Acute Coronary Syndrome |
| Q33699467 | Plasma NT pro-BNP, hs-CRP and big-ET levels at admission as prognostic markers of survival in hospitalized patients with dilated cardiomyopathy: a single-center cohort study |
| Q48469388 | Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction |
| Q48484544 | Plasma concentrations of atrial and brain natriuretic peptides in a case with hypertensive encephalopathy |
| Q38561217 | Plasma natriuretic peptides in children and adolescents with obstructive sleep apnea and their changes following intervention. |
| Q38424871 | Post-translational modifications enhance NT-proBNP and BNP production in acute decompensated heart failure |
| Q36223062 | Postoperative B-type natriuretic Peptide levels associated with prolonged hospitalization in hypertensive patients after non-cardiac surgery |
| Q38219481 | Potential impact of dipeptidyl peptidase-4 inhibitors on cardiovascular pathophysiology in type 2 diabetes mellitus |
| Q48881592 | Pre-discharge B-type natriuretic peptide predicts early recurrence of decompensated heart failure in patients admitted to a general medical unit |
| Q46016985 | Preload reserve is restored in patients with decompensated chronic heart failure who respond to treatment. |
| Q73905229 | Prognostic power of neurohumoral parameters in chronic heart failure depends on clinical stage and observation period |
| Q43915596 | Prognostic value of B-type natriuretic peptide in patients with chronic mitral regurgitation undergoing surgery: mid-term follow-up results |
| Q38642916 | Prognostic value of short-term follow-up BNP in hospitalized patients with heart failure. |
| Q37289370 | Quantitative phosphoproteomic study of pressure-overloaded mouse heart reveals dynamin-related protein 1 as a modulator of cardiac hypertrophy |
| Q34627120 | Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation. |
| Q82718531 | Relation of N-terminal pro-B-type natriuretic peptide (NT-proBNP) and left atrial volume index to left ventricular function in chronic hemodialysis patients |
| Q41686272 | Relation of Renal Function with Left Ventricular Systolic Function and NT-proBNP Level and Its Prognostic Implication in Heart Failure with Preserved versus Reduced Ejection Fraction: an analysis from the Korean Heart Failure (KorHF) Registry. |
| Q34219487 | Remodeling of the heart in hypertrophy in animal models with myosin essential light chain mutations |
| Q35900985 | Remodeling of the peripheral cardiac conduction system in response to pressure overload |
| Q40976394 | Renal denervation improves cardiac function in rats with chronic heart failure: Effects on expression of β-adrenoceptors |
| Q71514103 | Renal role of the endogenous natriuretic peptide system in acute congestive heart failure |
| Q80392917 | Response of the ECG to short-term diuresis in patients with heart failure |
| Q38089931 | Review on natriuretic peptides: where we are, where we are going |
| Q38871148 | Role of Angiotensin Receptor-Neprilysin Inhibition in Heart Failure |
| Q44564440 | Role of the epidermal growth factor receptor in signaling strain-dependent activation of the brain natriuretic peptide gene |
| Q48853747 | Roles of natriuretic peptides in heart failure |
| Q43131040 | SHP2 mediates gp130-dependent cardiomyocyte hypertrophy via negative regulation of skeletal alpha-actin gene |
| Q49924840 | Sacubitril/valsartan for heart failure with reduced left ventricular ejection fraction : A retrospective cohort study |
| Q44101661 | Steroid weaning in heart transplantation is associated with decreased B-type natriuretic peptide: surrogate evidence for cardiac adaptation |
| Q48637180 | Stretch-induced hypertrophic growth of cardiocytes and processing of brain-type natriuretic peptide are controlled by proprotein-processing endoprotease furin |
| Q33737153 | Structural and functional evolution of the natriuretic peptide system in vertebrates. |
| Q89482967 | The Confounding Effects of Non-cardiac Pathologies on the Interpretation of Cardiac Biomarkers |
| Q89414809 | The Effect of Left Ventricular Assist Device Therapy on Cardiac Biomarkers: Implications for the Identification of Myocardial Recovery |
| Q37369560 | The clinical utility of brain natriuretic peptide in paediatric left ventricular failure |
| Q35566122 | The diagnosis of acute congestive heart failure: role of BNP measurements |
| Q38022786 | The diagnostic utility of cardiac biomarkers in dialysis patients |
| Q39969199 | The effect of noncardiac disease on plasma brain natriuretic peptide concentration in dogs |
| Q48175628 | The effects of the selective ROCK inhibitor, Y27632, on ET-1-induced hypertrophic response in neonatal rat cardiac myocytes--possible involvement of Rho/ROCK pathway in cardiac muscle cell hypertrophy |
| Q34171357 | The natriuretic peptides: physiology and role in left-ventricular dysfunction. |
| Q24550992 | The neuron-restrictive silencer element-neuron-restrictive silencer factor system regulates basal and endothelin 1-inducible atrial natriuretic peptide gene expression in ventricular myocytes |
| Q39668034 | The relationship among brain natriuretic peptide (BNP), cholesterol and lipoprotein |
| Q49047965 | The synergistic combined effect of anemia with high plasma levels of B-type natriuretic peptide significantly predicts an enhanced risk for major adverse cardiac events |
| Q35856451 | The utility of BNP in clinical practice |
| Q38989945 | Timing of Dynamic NT-proBNP and hs-cTnT Response to Exercise Challenge in Asymptomatic Children with Moderate Aortic Valve Regurgitation or Moderate Aortic Valve Stenosis |
| Q73147177 | Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty |
| Q44299995 | Triiodothyronine increases brain natriuretic peptide (BNP) gene transcription and amplifies endothelin-dependent BNP gene transcription and hypertrophy in neonatal rat ventricular myocytes |
| Q36130511 | Understanding B-type natriuretic peptide and its role in diagnosing and monitoring congestive heart failure. |
| Q28217620 | Urocortin has cell-proliferative effects on cardiac non-myocytes |
| Q48669067 | Use of a B-type natriuretic peptide in evaluating the treatment response of a relapsed lymphoma with cardiac involvement |
| Q37109943 | Usefulness of the brain natriuretic peptide to atrial natriuretic peptide ratio in determining the severity of mitral regurgitation |
| Q46696940 | Utility of B-type natriuretic peptide in differentiating congestive heart failure from lung disease in pediatric patients with respiratory distress |
| Q73547043 | Vascular actions of brain natriuretic peptide: modulation by atherosclerosis and neutral endopeptidase inhibition |
| Q37375126 | Vitamin d predicts all-cause and cardiac mortality in females with suspected acute coronary syndrome: a comparison with brain natriuretic Peptide and high-sensitivity C-reactive protein |
| Q24338875 | Zinc-finger protein 90 negatively regulates neuron-restrictive silencer factor-mediated transcriptional repression of fetal cardiac genes |
| Q79331058 | [BNP tests in the emergency department to diagnose congestive heart failure] |
| Q87499438 | [Essential cardiac biomarkers in myocardial infarction and heart failure] |
| Q89966455 | [Multiparametric biochemical analysis revealing an increase of homocysteinemia and NT-proBNP in hypertensive patients living in Bamako (Mali)] |
Search more.